Company intelligence / Profile preview

ScalaMed

Sydney, New South Wales, Australia

Ownership: Private
Development stage: Other

Overview

ScalaMed developed a digital health platform that allows providers to send prescriptions directly to patients’ mobile devices, empowering patients to manage and fulfill their prescriptions and improving medication adherence. Clinical results focus on improved patient autonomy and reduced medication mismanagement, leading to better health outcomes[1][2][3].

Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on ScalaMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ScalaMed.

Explore the full profile